BeiGene
BGNE
#984
Rank
โ‚น1.695 T
Marketcap
โ‚น15,208
Share price
1.55%
Change (1 day)
0.37%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: โ‚น1.695 Trillion

As of December 2024 BeiGene has a market cap of โ‚น1.695 Trillion. This makes BeiGene the world's 984th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น1.695 T2.79%
2023โ‚น1.649 T-15.02%
2022โ‚น1.941 T-5.11%
2021โ‚น2.046 T16.42%
2020โ‚น1.757 T139.54%
2019โ‚น733.69 B25.89%
2018โ‚น582.79 B105.09%
2017โ‚น284.17 B247.13%
2016โ‚น81.86 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of BeiGene was reported to be:

โ‚น1.708 Trillion
by Yahoo Finance info icon info icon
โ‚น1.708 Trillion
by CompaniesMarketCap info icon info icon
โ‚น1.621 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น1.77 B-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น91.99 B-94.58%๐Ÿ‡บ๐Ÿ‡ธ USA